azor- amlodipine besylate and olmesartan medoxomil tablet, film coated
cosette pharmaceuticals, inc. - amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288), olmesartan medoxomil (unii: 6m97xtv3hd) (olmesartan - unii:8w1iqp3u10) - azor is indicated for the treatment of hypertension, alone or with other antihypertensive agents, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular (cv) events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with azor. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, ev
olmesartanmedoxomil/amlodipine stada 20 mg/5 mg filmomhulde tabletten
olmesartanmedoxomil/amlodipine stada 40 mg/10 mg filmomhulde tabletten
olmesartanmedoxomil/amlodipine stada 40 mg/5 mg filmomhulde tabletten
olmesartanmedoxomil/amlodipin accord 20 mg/5 mg filmtabletten
olmesartanmedoxomil/amlodipin accord 40 mg/10 mg filmtabletten
olmesartanmedoxomil/amlodipin accord 40 mg/5 mg filmtabletten
olmesartanmedoxomil amlodipin beta 20 mg/5 mg filmtabletten
olmesartanmedoxomil amlodipin beta 40 mg/10 mg filmtabletten
olmesartanmedoxomil amlodipin beta 40 mg/5 mg filmtabletten